Ulrike Gnad-Vogt
Directeur Technique/Scientifique/R&D chez CureVac SE
Postes actifs de Ulrike Gnad-Vogt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2011 | - |
Historique de carrière de Ulrike Gnad-Vogt
Anciens postes connus de Ulrike Gnad-Vogt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CUREVAC N.V. | Directeur Technique/Scientifique/R&D | 01/01/2011 | 01/01/2019 |
| Corporate Officer/Principal | 01/01/2019 | - |
Formation de Ulrike Gnad-Vogt
| Universität des Saarlandes | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Bourse
- Insiders
- Ulrike Gnad-Vogt
- Expérience
